NCI Emerging Technologies Seminar Series: Molecular and Computational Tools to Understand Tyrosine Phosphorylation in Cancer
Register for the October Emerging Technologies Seminar Series to hear from the University of Virginia’s Dr. Kristen Naegle as she discusses her work in understanding tyrosine phosphorylation in cancer research.
Dr. Naegle will share what she and her team at the Naegle Research Lab have learned about combining systems biology, computation, and experiments to predict and test the function of tyrosine phosphorylation in protein and protein networks.
She will also discuss the open source and broadly applicable molecular and computational tools they have developed. These include:
- a molecular toolkit for phosphorylated proteins and peptides, and
- an algorithm to predict kinase activity.
The NCI Emerging Technologies Seminar Series highlights novel technologies supported through NCI awards that could transform cancer research and clinical care.
Dr. Naegle is an associate professor of biomedical engineering at the University of Virginia and is the principal investigator at the Naegle Research Lab. Her research interests include molecular and cell bioengineering, quantitative cell biology, and systems biology.
- Human Tumor Atlas Network (HTAN) Data JamboreeDecember 04, 2023 - December 07, 2023Capturing Cancer Recurrence with Novel Data LinkagesDecember 05, 2023Cancer Vaccines, Identifying Druggable TargetsDecember 14, 2023